$25.81▴ 2.38%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Ultragenyx Pharmaceutical Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days2 articles
0 bullish0 neutral2 bearish
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - OSIS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
Why Is Ultragenyx (RARE) Up 6.4% Since Last Earnings Report?Amlogenyx to Present at the Wells Fargo 21ˢᵗ Annual Healthcare Conference
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)